[go: up one dir, main page]

IT1312568B1 - IMMUNOGENIC PEPTIDES AND THEIR USE. - Google Patents

IMMUNOGENIC PEPTIDES AND THEIR USE.

Info

Publication number
IT1312568B1
IT1312568B1 IT1999MI001121A ITMI991121A IT1312568B1 IT 1312568 B1 IT1312568 B1 IT 1312568B1 IT 1999MI001121 A IT1999MI001121 A IT 1999MI001121A IT MI991121 A ITMI991121 A IT MI991121A IT 1312568 B1 IT1312568 B1 IT 1312568B1
Authority
IT
Italy
Prior art keywords
immunogenic peptides
immunogenic
peptides
Prior art date
Application number
IT1999MI001121A
Other languages
Italian (it)
Inventor
Catia Traversari
Silvia Tanzarella
Claudio Bordignon
Original Assignee
Genera Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1999MI001121A priority Critical patent/IT1312568B1/en
Application filed by Genera Spa filed Critical Genera Spa
Priority to IL14660500A priority patent/IL146605A0/en
Priority to EP00935053A priority patent/EP1179019A2/en
Priority to HK02108670.8A priority patent/HK1047116A1/en
Priority to KR1020017014828A priority patent/KR20020011418A/en
Priority to CNB008092303A priority patent/CN1227264C/en
Priority to PCT/EP2000/004465 priority patent/WO2000071573A2/en
Priority to AU50676/00A priority patent/AU777474B2/en
Priority to CA002374354A priority patent/CA2374354A1/en
Priority to JP2000619828A priority patent/JP2003502026A/en
Publication of ITMI991121A1 publication Critical patent/ITMI991121A1/en
Application granted granted Critical
Publication of IT1312568B1 publication Critical patent/IT1312568B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IT1999MI001121A 1999-05-21 1999-05-21 IMMUNOGENIC PEPTIDES AND THEIR USE. IT1312568B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT1999MI001121A IT1312568B1 (en) 1999-05-21 1999-05-21 IMMUNOGENIC PEPTIDES AND THEIR USE.
EP00935053A EP1179019A2 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof
HK02108670.8A HK1047116A1 (en) 1999-05-21 2000-05-17 Immunogenic peptides and the use thereof
KR1020017014828A KR20020011418A (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from MAGE and the use thereof
IL14660500A IL146605A0 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof
CNB008092303A CN1227264C (en) 1999-05-21 2000-05-17 Immunogenic peptides from MAGE and their use
PCT/EP2000/004465 WO2000071573A2 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof
AU50676/00A AU777474B2 (en) 1999-05-21 2000-05-17 Immunogenic peptides and the use thereof
CA002374354A CA2374354A1 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof
JP2000619828A JP2003502026A (en) 1999-05-21 2000-05-17 MAGE-derived immunogenic peptides and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001121A IT1312568B1 (en) 1999-05-21 1999-05-21 IMMUNOGENIC PEPTIDES AND THEIR USE.

Publications (2)

Publication Number Publication Date
ITMI991121A1 ITMI991121A1 (en) 2000-11-21
IT1312568B1 true IT1312568B1 (en) 2002-04-22

Family

ID=11383013

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001121A IT1312568B1 (en) 1999-05-21 1999-05-21 IMMUNOGENIC PEPTIDES AND THEIR USE.

Country Status (10)

Country Link
EP (1) EP1179019A2 (en)
JP (1) JP2003502026A (en)
KR (1) KR20020011418A (en)
CN (1) CN1227264C (en)
AU (1) AU777474B2 (en)
CA (1) CA2374354A1 (en)
HK (1) HK1047116A1 (en)
IL (1) IL146605A0 (en)
IT (1) IT1312568B1 (en)
WO (1) WO2000071573A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US6291430B1 (en) * 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
EP1124834B1 (en) * 1998-10-29 2002-11-06 The Dow Chemical Company Preparation of titanium(ii) or zirconium(ii) complexes

Also Published As

Publication number Publication date
JP2003502026A (en) 2003-01-21
IL146605A0 (en) 2002-07-25
WO2000071573A2 (en) 2000-11-30
AU777474B2 (en) 2004-10-21
HK1047116A1 (en) 2003-02-07
CA2374354A1 (en) 2000-11-30
CN1360595A (en) 2002-07-24
AU5067600A (en) 2000-12-12
WO2000071573A3 (en) 2001-04-05
KR20020011418A (en) 2002-02-08
CN1227264C (en) 2005-11-16
ITMI991121A1 (en) 2000-11-21
EP1179019A2 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
IS6040A (en) Valdekoxib preparations
DK1210113T3 (en) Combined vaccine preparations
NL1015859A1 (en) Pharmaceutical preparations.
EP1329217A4 (en) SOLID PREPARATIONS
BR0017112B1 (en) Water soluble bag composition and use of the composition.
MXPA02004770A (en) THERAPEUTIC COMPOSITIONS AND METHODS FOR USE.
NO20013883L (en) Freeze-dried agent containing paramylon, as well as the preparation and use thereof
MXPA03003283A (en) IMPROVED ZEOLITES AND MOLECULAR SIZES AND ITS USE.
MXPA03004932A (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors.
DE60135797D1 (en) leatherette
FR2791348B1 (en) POLYPEPTIDE Npt2B
IT1291823B1 (en) PSEUDO-PEPTIDE COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS
IT1312568B1 (en) IMMUNOGENIC PEPTIDES AND THEIR USE.
NO20013933D0 (en) peptides
IT1310419B1 (en) PIN FOR DENTAL USE.
DE50009295D1 (en) NETWORK-FREE PREPARATIONS
FR2798017B1 (en) DEPHASER, AND DEMODULATOR USING THE SAME
IT1317895B1 (en) PSEUDO-METALLOPROTEIN, THEIR PREPARATION AND THEIR USE.
IT1307020B1 (en) N-NITRO-DINITRO-ANYLENE N-DENITRATION PROCEDURE IN PHASEOMOGENEOUS.
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
ATA90082000A (en) SEATING
FI4153U1 (en) Canopies
ITMI981503A1 (en) MINIATURE HEMOPROTEINS, THEIR PREPARATION AND THEIR USE
ES1046144Y (en) PERFECTED UMBRELLA.
ES1044492Y (en) PARASOL.